Background: Tissue inhibitor of metalloproteinases-3 (TIMP3) is the third member of the TIMP family of proteins, believed to play a significant role in controlling extracellular matrix remodeling. Materials and Methods: Differential screening of a human breast carcinoma cDNA library using substracted and PCR-amplified cDNA probes identified a 4.6-kb TIMP3 cDNA, which was used for further cDNA library screenings, Northern blot hybridizations, and the synthesis of riboprobes for in situ RNA hybridization analyses. Results: The 4.6-kb full-length TIMP3 cDNA contains 3.7 kb of 3'-untranslated sequence. Additional TIMP3 cDNAs subsequently identified were colinear with the original sequence, but revealed use of four different polyadenylation signals within the 3'-untranslated re-
INTRODUCTION
TIMP3 represents a novel member of the tissue inhibitor of metalloproteinases (TIMP) protein family, previously comprised of TIMPI and TIMP2 proteins (1) . The chicken TIMP3 sequence, which was the first to be identified, shows 28 and 42% amino acid identity with consensus TIMPI and TIMP2 amino acid sequences, respectively (1), and is approximately as similar to TIMP2 as TIMPI and TIMP2 are to each other (2) . All TIMP proteins so far identified function as inhibitors of the matrix metalloproteinase family of enzymes. The physiological role of these enzymes is believed to be the degradation of extracellular matrix components, with matrix metalloproteinase activity being implicated in both physiological and pathological tissue remodeling processes (3) (4) (5) . TIMP function appears vital for correct regulation of matrix metalloproteinase activity (6) , and in the case of TIMP3, elevated gene expression (7) and coding sequence mutations (8) have been recently re-ported in two retinal disorders characterized by increased local remodeling of the extracellular matrix.
Either as a consequence or independent of their functions as inhibitors of matrix metalloproteinases, TIMPs affect cellular growth (9) . TIMPI was initially known as erythroid-potentiating activity due to its ability to stimulate colony formation by erythroid precursors (10) , and has been shown to stimulate the growth of a variety of cells in culture (11) . Erythroid-potentiating activity has been subsequently demonstrated for TIMP2 (12) , which has also been found to inhibit basic fibroblast growth factor-induced endothelial cell proliferation (13) . TIMP3 is especially interesting in this regard, having been found to possess tumor-promoting properties, such as the ability to promote the detachment of transformed chicken embryo fibroblasts from the extracellular matrix (14) .
TIMP3 cDNAs have been recently isolated from chicken (1), mouse (15) (16) (17) and human (7, (18) (19) (20) (21) (22) . However, the lengths of the human cDNA sequences published to date do not correspond with the sizes of the 3 most prominent human TIMP3 transcripts noted in previous studies (18) (19) (20) 22) , although a sequence approximating the length of the largest transcript has been reported in the mouse (16) . Furthermore, although TIMP3 transcripts are detected in samples of oligodT-selected RNA (17) (18) (19) , several of the TIMP3 cDNAs described do not have polyA sequences (1, 7, 15, 17, 18) , suggesting that these are incomplete at least at their 3' ends. It has been suggested that multiple TIMP3 transcripts arise by alternative splicing involving coding and/or noncoding regions, further processing of the longest transcript, the use of alternate polyadenylation sites, or that the presence of multiple TIMP3 transcripts may actually represent the existence of additional, highly homologous genes (18) (19) (20) 22) . In the absence of cDNA clones corresponding to the most frequently observed TIMP3 transcripts, it is currently unclear which of these mechanisms operate in vivo.
In the course of a differential screening procedure designed to isolate genes that are commonly overexpressed in human carcinomas, we identified a number of cDNAs that were differentially expressed between breast carcinomas and fibroadenomas (23) . Following DNA sequencing, one cDNA clone containing a 4.6-kb insert was found to encode human TIMP3. Unlike human TIMP3 cDNAs previously reported, its length corresponded to that of the longest and most predominant TIMP3 transcript in human and mouse RNA samples (7, (15) (16) (17) (18) (19) (20) . A second screening of the breast carcinoma cDNA library and an additional library constructed using metastatic lymph node tissue from a breast cancer patient, identified other TIMP3 clones. The analysis of 5 cDNA clones revealed that 4 distinct polyadenylation sites are used.
In situ RNA hybridization analyses were performed on paraffin-embedded tissue sections to determine the cellular localization of TIMP3 Arlington Heights, IL, U.S.A.). Northern blot hybridizations were performed using the 32P-labeled S6 TIMP3 cDNA (see above), and subsequently using that of 36B4, a gene known to be ubiquitously expressed (26) . These and following washing steps were performed essentially as described (25) , and filters were exposed to Kodak XAR film for 6 hr to 3 days at -800C.
In situ hybridizations were performed on formaldehyde-fixed paraffin-embedded human tissue sections as described (25) . Briefly, 5-,um sections that had been deparaffined and acidtreated were treated with proteinase K and hybridized overnight at 55°C with sense or antisense TIMP3 transcripts labeled with 35S-CTP. Transcripts were synthesized using either T3 or T7 polymerases and plasmid DNA templates purified from two CsCl gradients and digested with appropriate restriction enzymes. Two cDNAs were used to synthesize probes: the 4579 bp S6 cDNA including 3666 bp of 3'-UTR sequence; and a 1976 bp S6 TIMP3 subclone including the S6 5'-untranslated region (UTR) and coding sequences, but only 1063 bp of 3'-UTR sequence (see Results). Hybridizations were followed by RNAse treatment as described (25) , and washing (2X SSC, 50% formamide, at 550C for 2 hr), before autoradiography using NTB2 emulsion (Kodak, Rochester, NY, U.S.A.) at 40C for 14 to 32 days. After development, sections were counterstained with toluidine blue.
RESULTS
Isolation of the S6 Clone and of Additional Homologous Clones The cDNA clone containing an insert of 4.6 kb, originally identified in the differential screening procedure, was given the laboratory designation of S6. Use of this clone in Northern blot hybridizations resulted in the frequent detection of 3 transcripts of 4.6, 2.7, and 2.5 kb in length (Fig.  1 ). These were strongly expressed in the breast carcinoma from which both the cDNA library and the probes used for differential screening were derived, but were only weakly expressed in the breast fibroadenoma used to subtract the breast carcinoma cDNA. The 3 transcripts were consistently detected together in most human tissues and cell lines examined, although the largest transcript was missing in HeLa and Caco-2 cells (Fig. 1) . In addition to the 2.7-and 2.5-kb transcripts, 2. were also detected in the metastatic lymph node from which the second cDNA library screened in this study was obtained (data not shown).
The length of the 4.6-kb insert of the S6 clone suggested that this represents a full-length cDNA clone corresponding to the largest transcript detected by Northern blot analysis (Fig. 1) quences from SI 0, will be referred to hereafter as the S6/10 sequence (Fig. 2) (28) . The remaining AGGAAA polyadenylation signal identified was classified as being nonrecognizable, differing by 2 nucleotides or more from the six nucleotide consensus (27) , and the use of a similar AAGAAA signal was found to diminish the efficiency of polyadenylation by approximately 94% (28) . Such hexanucleotide sequences are uncommonly encountered, and the AGGAAA polyadenylation signal was not found to be conserved in the murine TIMP3 3'-UTR (16 (28, 29) . This would appear to be the case for the AGGAAA and AGTAAA signals identified in the 2.7-and 4.6-kb TIMP3 transcripts in the present study. Both these TIMP3 transcripts are readily detectable in a range of tissues by Northern blot analyses (18, 22) , despite the use of polyadenylation signals which should significantly impair transcript cleavage and polyadenylation. Thus, it would appear that mRNA cleavage and polyadenylation alone do not limit the levels of all TIMP3 transcripts. The use of alternative polyadenylation signals to derive multiple TIMP3 transcripts may be significant in allowing the length and sequence composition of the extensive 3'-UTR to be modulated. Regardless, the choice between the various TIMP3 polyadenylation sites is likely controlled in part by cell-and/or tissue-specific factors, explaining the absence of particular TIMP3 transcripts in certain tissues and cell lines, as noted in this and previous studies (17) (18) (19) 21 ).
The present study represents the first instance in which in situ TIMP3 gene expression has been investigated in human tissues, although it has been examined in the developing mouse embryo at 12.5 and 14.5 days gestation, and in the newborn mouse (17) . During mouse development, the expression of TIMP3 was noted to be prominent in the epithelial component of many organs, and TIMP3 was proposed to play a role in the development of skeletal and cardiac muscle, the morphogenesis of epithelial structures, and in placental implantation (17) . In contrast, we observed in the present study that TIMP3 transcripts were predominantly expressed in stromal cells of the human tissues examined. In particular, the pattern of TIMP3 gene expression noted in human placenta was strikingly different from that noted in the mouse (17 (32) . However, TIMP2 transcripts were localized to stromal cells in colorectal (33) , head and neck (32) , and breast carcinomas (34) . Hence, the pattern of TIMP3 gene expression in breast carcinomas described in the present study appears to resemble that previously noted for TIMP2, where both genes appear to be predominantly stromally expressed.
In biological processes where net proteolytic enzyme activity is enhanced such as tumor development and angiogenesis, the concomitant synthesis of inhibitors is nonetheless required to regulate proteolytic activity (35) (36) (37) (38, 39 and references therein). In addition, TIMP3 has been noted to promote the detachment of transforming chicken embryo fibroblasts from the extracellular matrix, as well as accelerating morphological changes associated with cell transformation (14) . Thus, it could also be envisaged that TIMP3 facilitates the migration and accumulation of fibroblastic cells into the tumor stroma. This might, in turn, enhance cancer growth, since the tumor stroma is usually believed to be necessary for carcinoma expansion (40, 41) . Thus, while a tumor suppressor function has been previously suggested for TIMP3 (16) , it is equally possible that TIMP3 may function to promote tumor progression.
